Liberty Mutual Group Asset Management’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
– Sell
-8,671
Closed -$1.11M – 753
2018
Q3
$1.11M Sell
8,671
-1,461
-14% -$181K 0.02% 337
2018
Q2
$1.15M Buy
10,132
+161
+2% +$17.7K 0.03% 312
2018
Q1
$1.12M Sell
9,971
-2,518
-20% -$320K 0.03% 328
2017
Q4
$1.85M Sell
12,489
-759
-6% -$96.5K 0.05% 198
2017
Q3
$1.55M Sell
13,248
-4,797
-27% -$613K 0.09% 248
2017
Q2
$2.34M Sell
18,045
-2,414
-12% -$301K 0.09% 238
2017
Q1
$2.77M Buy
20,459
+1,100
+6% +$167K 0.11% 211
2016
Q4
$2.78M Sell
19,359
-103
-0.5% -$13.2K 0.1% 218
2016
Q3
$2.3M Sell
19,462
-229
-1% -$27.5K 0.08% 268
2016
Q2
$2.08M Sell
19,691
-3,100
-14% -$346K 0.08% 292
2016
Q1
$2.54M Sell
22,791
-6,567
-22% -$831K 0.11% 200
2015
Q4
$4.6M Buy
29,358
+9,960
+51% +$1.45M 0.18% 104
2015
Q3
$2.55M Buy
19,398
+16
+0.1% +$2.57K 0.1% 221
2015
Q2
$3.37M Buy
19,382
+3,544
+22% +$638K 0.12% 167
2015
Q1
$2.73M Buy
15,838
+623
+4% +$95K 0.08% 289
2014
Q4
$1.97M Sell
15,215
-153
-1% -$19.7K 0.06% 570
2014
Q3
$1.98M Buy
15,368
+1,242
+9% +$128K 0.06% 465
2014
Q2
$1.25M Sell
14,126
-590
-4% -$56.7K 0.04% 803
2014
Q1
$1.38M Buy
14,716
+4,693
+47% +$480K 0.05% 748
2013
Q4
$1.13M Sell
10,023
-4,314
-30% -$389K 0.04% 741
2013
Q3
$1.13M Sell
14,337
-4,716
-25% -$345K 0.04% 534
2013
Q2
$1.25M Buy
+19,053
New +$1.23M 0.05% 478

Other funds holding UTHR

Liberty Mutual Group Asset Management's UTHR Position: Q4 2018 in Review

Liberty Mutual Group Asset Management sold out of United Therapeutics (UTHR) in Q4 2018, closing a stake of 8,671 shares — an estimated $1.11M sold.

Liberty Mutual Group Asset Management first reported a position in UTHR in Q2 2013 and held it in 22 quarters. The position peaked at $4.6M in Q4 2015. 360 funds tracked by Wall St. Rank hold UTHR as of Q4 2018.

  • Liberty Mutual Group Asset Management reported no remaining United Therapeutics position as of Q4 2018 after selling out during the quarter.
  • Liberty Mutual Group Asset Management sold 8,671 United Therapeutics shares in Q4 2018, an estimated $1.11M.
  • Liberty Mutual Group Asset Management first reported a position in United Therapeutics in Q2 2013 and held it in 22 quarters.
  • Liberty Mutual Group Asset Management's United Therapeutics position peaked at $4.6M in Q4 2015.
  • 360 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2018.

Based on Liberty Mutual Group Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.